Posted by frtaylor on 17th of Sep 2012 at 11:45 am
Currently 5.79. It's off 20% from its high last week.
I sold all of mine (not at the high, of course).
Sitting on the 20dma right now. 50dma is another buck
down. 61.8% retrace is at 5.71. Matt, any thoughts?
frtaylor - AUMN priced a secondary offering at $5.75 on Friday
and thus the reason for the drop in price.
With the junior golds and biotechs, one has to always be aware
of possible financing into upward price movement and thus it's wise
to have an idea of where such companies stand with respect to cash
on their balance sheet.
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
AUMN - anyone buying?
Posted by frtaylor on 17th of Sep 2012 at 11:45 am
Currently 5.79. It's off 20% from its high last week. I sold all of mine (not at the high, of course). Sitting on the 20dma right now. 50dma is another buck down. 61.8% retrace is at 5.71. Matt, any thoughts?
thx guys, good information!
Posted by frtaylor on 17th of Sep 2012 at 12:15 pm
thx guys, good information!
I sold half my position
Posted by hamvestor on 17th of Sep 2012 at 12:05 pm
I sold half my position this morning. I'm beginning to lose confidence in the commitment of management to enhancing shareholder value.
frtaylor - AUMN priced a
Posted by steve on 17th of Sep 2012 at 12:02 pm
frtaylor - AUMN priced a secondary offering at $5.75 on Friday and thus the reason for the drop in price.
With the junior golds and biotechs, one has to always be aware of possible financing into upward price movement and thus it's wise to have an idea of where such companies stand with respect to cash on their balance sheet.